Pivya Tablet, Coated
NDC Package 62332-966-09

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Pivya (pivmecillinam) tablets is pIVYA is indicated for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli (E. This formulation utilizes a tablet, coated delivery system. Marketed by Alembic Pharmaceuticals Inc., this product is identified by NDC 62332-966 and is authorized under FDA application NDA216483.

Identification & Billing

NDC Package Code
62332-966-09
Package Description
1 BLISTER PACK in 1 CARTON / 9 TABLET, COATED in 1 BLISTER PACK
Product Code
62332-966
11-Digit Billing Format
62332096609
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pivya
Non-Proprietary Name
Pivmecillinam
Substance Name
Pivmecillinam Hydrochloride
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PIVMECILLINAM HYDROCHLORIDE 185 mg/1
Usage Information
PIVYA is indicated for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli (E. coli), Proteus mirabilis, and Staphylococcus saprophyticus.

Regulatory & Marketing

Labeler Name
Alembic Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA216483
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-02-2026
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62332-966-09 identifies a specific commercial package of 1 blister pack in 1 carton / 9 tablet, coated in 1 blister pack of Pivya, a human prescription drug labeled by Alembic Pharmaceuticals Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet, coated is formulated for oral use and contains pivmecillinam hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Inc. on February 02, 2026. The current certification is valid through December 31, 2026.

How is this Alembic Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62332096609. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62332-966-09
11-Digit CMS (5-4-2)
62332-0966-09

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.